My Cart : 0 item(s) / $0.00

GW-501516 10mg (30ML)

Availability: In stock

Ships today if ordered in the next 1 hour and 20 minutes!

Unit Price: $99.99

$73.50

 Free shipping on orders over $99

Buy GW-501516 10mg (30ML)

Double click on above image to view full picture

Zoom Out
Zoom In
Unit Size 10mg per ml (300mg per bottle)
Appearance Clear with small partials (Shake well before researching)
CAS NO. 317318-70-0
Molecular Weight 453.5
Molecular Formula

C21H18F3NO3S2

Manufactured United States
Reports

»Certificate of Analysis

»HPLC Report

»Mass Spectrum

Unit Quantity 30ml Bottle
Physical State Liquid
Storage Gw-501516 may be stored at Room Temperature and out of direct sunlight until the expiration date.
Terms The products we offer are intended for laboratory research use only. Please familiarize yourself with our Terms and conditions prior to ordering.

GW-501516 10mg (30ML) 

The peptide GW-501516 is a PPARδ receptor agonist that sometimes goes by the names GW501516, GW-501,516, GW1516, GSK-516, and Endurobol. Its molecular formula is C21H18F3NO3S2, and it contains a molecular mass of 453.498.

Functionality of GW-501516

According to scientific study on animal test subjects, GW-501516 has been shown to activate PPARδ receptors, which are nuclear hormone receptors that have been shown to control and regulate a host of biological processes. It has also been shown to activate receptors relating to AMP-activated protein kinase, which is an enzyme that has been shown to play a role in providing cellular energy homeostasis. These particular actions, which are caused by the peptide binding to these particular receptors, have been shown to increase fatty acid metabolism in skeletal muscle.

Theoretical Benefits of GW-501516

Because of the way in which GW-501516 binds to PPARδ and AMP-activated protein kinase receptors, scientific studies on animal test subjects has determined that the presence of the peptide could play a role in regulating obesity as well as select secondary conditions that could relate to obesity. Studies on lab rats have indicated that the peptide’s capacity to increase fatty acid metabolism could conceivably aid in the prevention of diet-induced obesity as well as type II diabetes. Further studies on obese rhesus monkeys have indicated that the peptide mechanism has led to an increase in high-density lipoprotiein (HDL) and a decrease in very-low-density lipoprotein (VLDL).

Set Aside for Scientific Research

It should be emphasized that despite the extensive amount of research and study that has been conducted in order to pinpoint the functionality and mechanics of GW-501516, it is only intended for the sole use of scientific study at this time. Any findings or observations that can be tied to GW-501516 should exclusively be contained to a laboratory, a medical research facility, or another strictly controlled environment in this vein.

For more research essays please visit our blog by clicking here

First Shipping
Free First Class Shipping